drugset / Trial / NCT00546676
Ketek in CAP / AECB in Ambulatory Adult Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine the clinical effectiveness of telithromycin in the treatment of either CAP or AECB in a large population of ambulatory adult patients in a community-based setting.
Timeline
- Start
- 2004-05
- Primary completion
- —
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telithromycin | Small molecule | 800 mg | Oral |